US Edition
Biontech Rolls Out New Clinical Trials with Cancer Patients
Summary by Berliner-sonntagsblatt.de
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The Mainz-based pharmaceutical company BioNTech, together with its partner Bristol Myers Squibb (BMS), is aggressively advancing cancer research. More than ten new trials, each with 500 to 1,000 patients, are to be rolled out worldwide in the coming months, company founders Ugur Sahin and Özlem Türeci told the business magazine Capital. "We see this as a potential standard treatment for many types of cancer," Sahin continued. BioNTech's new hope…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
